Evidence map›Paper›PMID 38473380›Full record

ReviewCancers2024

The PAX Genes: Roles in Development, Cancer, and Other Diseases.

Taryn Shaw, Frederic G Barr, Aykut Üren

Abstract readReview
In one paragraph

Review in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Epigenetic, Genetic, and Functional Germline Alterations ofCurrent issues in molecular biology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. PAX Family, Master Regulator in Cancer.Diagnostics (Basel, Switzerland) · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Role of the PAX Genes in Renal Cell Carcinoma.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Taryn ShawDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20001, USA.ORCID 0009-0003-6690-0335
Frederic G BarrLaboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA.
Aykut ÜrenDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20001, USA.ORCID 0000-0002-2033-1216

Funding

Pharmacological Sciences Training Program (PSTP)T32GM142520 · NIGMS · GEORGETOWN UNIVERSITY · PI Patrick Alexander Forcelli, Anton Wellstein · 2022 to 2026
$1.3M
NIGMS NIH HHS 5T32GM142520-02NIGMS NIH HHS T32 GM142520
6 · The paper itself

Abstract

Since their 1986 discovery in

Indexed as

cancercancer therapeuticsdevelopmental disordersPAX fusionsPAX genesPAX proteins

Identifiers

PMID38473380
PMCPMC10931086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.